Congratulations to the
2019 Visionary Awards Recipients
Alnylam Pharmaceuticals for leading the way in a new classof innovative medicines using RNA interference to transform the lives of people afflicated with rare genetic, cardio-metabolic, and hepatic infectious diseases.
Biogen and the Biogen Foundation for the creation of STAR a Coordinated Ecosystem of local nonprofits aimed at helping Cambridge & Somerville public school students pursue STEM education.
Ed Fritsch and his dedicated team at ACIR ( Accelerating Cancer Immunotherapy Research) for helping researchers stay on top of new literature in the fast-moving concer immunotherapy field by fostering researcher's productivity to bring us closer to curing this deadly disease.
The Foundry Consortium for their collaborative effort to create a self-sustaining center for Arts + STEM for the diverse communities of Cambridge.
Michael Monestime and the Central Square Commercial Property Owners for their advocacy, collabortaion and vision to make the Central Square Business Improvement District (BID) a reality.
Philips Healthcare for their development of the Precision Infection Prevention software: IntelliSpace Epidemiology Information System. This solution helps hospitals stop healthcare associated infections with clinical informatics ad pathogen genomics.
Rubius Therapeutics for their development of the new class of cellular medicines, Red Cell Therapeutics. These life-changing cellular therapies are in development to treat metabolic disorders, cancer, and autoimmune diseases.
Sage Therapeuitcs for developing and bringing to market the first and only medicine specifically approved to treat Postpartum Depression (PPD), a common complication of pregnancy that affects more than 400,000 women in the U.S. annually.